Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000088690

Apexbio Technology LLC Afuresertib 1047644-62-1 100mg
SDP

Catalog No. 5000088690
Encompass_Preferred

Afuresertib (CAS 1047644-62-1) is a small molecule inhibitor targeting the serine/threonine protein kinase Akt (also known as protein kinase B) a key component of the PI3K/Akt signaling pathway involved in cell proliferation survival and metabolism By inhibiting Akt activity afuresertib modulates downstream signaling cascades that contribute to oncogenesis and tumor progression This compound has been investigated in preclinical models and clinical trials for its potential to suppress malignant cell growth particularly in studies involving solid tumors and hematologic malignancies Its use facilitates exploration of Akt pathway inhibition in cancer research

Catalog No. 50-000-88690 Supplier Apexbio Technology LLC Supplier No. B4811100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Afuresertib (CAS 1047644-62-1) is a small molecule inhibitor targeting the serine/threonine protein kinase Akt (also known as protein kinase B) a key component of the PI3K/Akt signaling pathway involved in cell proliferation survival and metabolism By inhibiting Akt activity afuresertib modulates downstream signaling cascades that contribute to oncogenesis and tumor progression This compound has been investigated in preclinical models and clinical trials for its potential to suppress malignant cell growth particularly in studies involving solid tumors and hematologic malignancies Its use facilitates exploration of Akt pathway inhibition in cancer research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.